Volume | 8 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.16 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
2 | 8 | - | 1.69 - 3.64 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
06:13:21 | 5 | $ 3.18 | USD |
Arbutus Biopharma Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
567.2M | 179.49M | - | 18.14M | -72.85M | -0.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arbutus Biopharma News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABUS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.31 | 3.31 | 3.08 | 3.19 | 1,024,686 | -0.15 | -4.53% |
1 Month | 2.93 | 3.64 | 2.89 | 3.30 | 1,146,035 | 0.23 | 7.85% |
3 Months | 2.55 | 3.64 | 2.30 | 3.02 | 1,295,639 | 0.61 | 23.92% |
6 Months | 2.15 | 3.64 | 2.125 | 2.82 | 1,122,686 | 1.01 | 46.98% |
1 Year | 2.50 | 3.64 | 1.69 | 2.54 | 881,940 | 0.66 | 26.40% |
3 Years | 3.30 | 6.50 | 1.69 | 3.50 | 1,914,281 | -0.14 | -4.24% |
5 Years | 1.54 | 9.00 | 0.81 | 3.66 | 2,080,147 | 1.62 | 105.19% |
Arbutus Biopharma Description
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. |